ANI Pharmaceuticals announced it will release its second quarter 2026 financial results on August 7, 2026, at 8:00 a.m. ET. The company’s executives will host a webcast and conference call to discuss the results, accessible via the company’s website. ANI focuses on growth through its Rare Disease, Generics, and Brands businesses, highlighting its commitment to innovative therapeutics. Investors can access a replay of the event for up to one year.
Evercore ISI raised Ross Stores' price target to $276, suggesting a 12.5% upside from its current $245.36 price. The boost reflects strong expectations for Q2, with projected revenues of $6.10 billion (up 10.7%) and earnings per share of $1.92 (up 23...
Fabrinet is set to report strong Q3 2026 earnings with revenue forecasted at about $1.276 billion, a 41% increase year-over-year, driven by demand in Telecom and Data Center sectors. Earnings per share are expected to rise 45% to $3.81, reflecting ro...
Jernigan Capital, a REIT specializing in financing self-storage facilities, saw its stock rise over 11% to $24.00, reaching a new 52-week high. Analysts have a consensus "Moderate Buy" rating with an average 12-month price target of $27.50, suggestin...
CrowdStrike, a leading cybersecurity firm, has seen its stock price increase by 85% year-to-date, reaching a market cap over $220 billion. Investment firm Cowen & Co. reiterated a "Buy" rating and raised the price target to $235, citing strong financ...
Ferrari, led by CEO Benedetto Vigna, significantly outperforms Tesla in key financial metrics: return on equity (45.4% vs. 4.67%), return on assets (13.6% vs. 1.93%), and operating margin (31.1% vs. 1.41%). Vigna, a former semiconductor executive, ha...
